A066700 Stock Overview
Engages in the research and development, production, and sale of pharmaceutical products in Korea.
| Snowflake Score | |
|---|---|
| Valuation | 3/6 |
| Future Growth | 0/6 |
| Past Performance | 4/6 |
| Financial Health | 6/6 |
| Dividends | 0/6 |
Theragen Etex Co.,Ltd. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | ₩3,840.00 |
| 52 Week High | ₩5,110.00 |
| 52 Week Low | ₩2,800.00 |
| Beta | 0.42 |
| 11 Month Change | -0.13% |
| 3 Month Change | -1.66% |
| 1 Year Change | -14.95% |
| 33 Year Change | -49.21% |
| 5 Year Change | -45.30% |
| Change since IPO | -37.76% |
Recent News & Updates
Estimating The Fair Value Of Theragen Etex Co.,Ltd. (KOSDAQ:066700)
Aug 07
Theragen EtexLtd's (KOSDAQ:066700) Solid Profits Have Weak Fundamentals
Mar 27Recent updates
Estimating The Fair Value Of Theragen Etex Co.,Ltd. (KOSDAQ:066700)
Aug 07Theragen EtexLtd's (KOSDAQ:066700) Solid Profits Have Weak Fundamentals
Mar 27Calculating The Intrinsic Value Of Theragen Etex Co.,Ltd. (KOSDAQ:066700)
Mar 21Is Theragen EtexLtd (KOSDAQ:066700) A Risky Investment?
Feb 11
Did Theragen EtexLtd's (KOSDAQ:066700) Share Price Deserve to Gain 36%?
Jan 16A Look At The Intrinsic Value Of Theragen Etex Co.,Ltd. (KOSDAQ:066700)
Dec 21We're Not So Sure You Should Rely on Theragen EtexLtd's (KOSDAQ:066700) Statutory Earnings
Nov 23Shareholder Returns
| A066700 | KR Pharmaceuticals | KR Market | |
|---|---|---|---|
| 7D | 3.6% | 4.5% | 2.9% |
| 1Y | -15.0% | 13.5% | 4.4% |
Return vs Industry: A066700 underperformed the KR Pharmaceuticals industry which returned 13.5% over the past year.
Return vs Market: A066700 underperformed the KR Market which returned 4.4% over the past year.
Price Volatility
| A066700 volatility | |
|---|---|
| A066700 Average Weekly Movement | 5.0% |
| Pharmaceuticals Industry Average Movement | 6.4% |
| Market Average Movement | 6.5% |
| 10% most volatile stocks in KR Market | 12.1% |
| 10% least volatile stocks in KR Market | 3.4% |
Stable Share Price: A066700 has not had significant price volatility in the past 3 months.
Volatility Over Time: A066700's weekly volatility (5%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1987 | 202 | Jin-Yeob Go | www.theragenetex.com |
Theragen Etex Co.,Ltd., together with its subsidiaries, engages in the research and development, production, and sale of pharmaceutical products in Korea. It offers drugs in the fields of circulatory, respiratory, digestive, antibiotics, antifungals, analgesic, endocrine and metabolic, hepatoprotective, psychotropic, urinary system, skeletal muscle, PMS, anthelmintic, nutrition, and others. The company was formerly known as Theragen Co., Ltd.
Theragen Etex Co.,Ltd. Fundamentals Summary
| A066700 fundamental statistics | |
|---|---|
| Market cap | ₩122.90b |
| Earnings (TTM) | ₩27.77b |
| Revenue (TTM) | ₩231.95b |
4.4x
P/E Ratio0.5x
P/S RatioIs A066700 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| A066700 income statement (TTM) | |
|---|---|
| Revenue | ₩231.95b |
| Cost of Revenue | ₩121.46b |
| Gross Profit | ₩110.49b |
| Other Expenses | ₩82.72b |
| Earnings | ₩27.77b |
Last Reported Earnings
Mar 31, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 867.72 |
| Gross Margin | 47.63% |
| Net Profit Margin | 11.97% |
| Debt/Equity Ratio | 19.3% |
How did A066700 perform over the long term?
See historical performance and comparison